Topic Statement: TechM has been stuck in a consolidation zone, rebounding from strong support levels and forming a wedge pattern that may signal an upcomingView More
Month: July 2025
DMart (Avenue Supermarts): A Retail Powerhouse Navigating Cost Pressures in FY26
India’s Value Retail Flagship Continues Its Expansion Amid Margin Headwinds India’s retail landscape is undergoing a quiet revolution—and at the center of this transformation standsView More
When Subsidiaries Become a Burden: Lessons from GMR Infra, Andhra Sugars, and Tata Power
Most blue-chip companies today are not confined to a single line of business. Instead, they resemble sprawling conglomerates, operating through subsidiaries that span multiple industriesView More
ICICI Prudential Life Insurance Moves Steadily in Mild Bullish Channel, Faces Key Resistance
Topic Statement: ICICI Pru Life is moving with mild bullish momentum, supported by strong levels but approaching critical resistance zones. Key Points:
TCS’s Losing Streak: Why Investors Are Tilting Toward Infosys and HCLTech
Tata Consultancy Services Ltd (TCS), India’s largest IT services firm, is facing a period of introspection. After three consecutive quarters of revenue decline, TCS isView More
Cipla Trades Sideways Within Defined Range, Eyes Possible Double Top Ahead
Topic Statement: Cipla is currently stuck in a sideways zone, consolidating between key retracement levels while setting up for a potential move higher. Key Points:
Why Balrampur Chini and EID Parry Are Sweet Spots in India’s Bitter Sugar Market
India’s sugar sector is currently facing a perfect storm: weak domestic prices, tight government export controls, and uncertainty around ethanol blending policies. As a result,View More
Coforge’s Consulting Playbook: Borrowing a Page from the Titans to Drive Future Growth
Coforge Ltd, formerly known as NIIT Technologies, has quietly but firmly set its sights on becoming a bigger force in the IT services landscape. InView More
Glenmark’s Landmark Licensing Deal: A Giant Leap for Indian Biopharma
In a groundbreaking move that has put India’s pharmaceutical innovation firmly on the global map, Glenmark Pharmaceuticals Ltd’s US-based unit, Ichnos Glenmark Innovation (IGI), hasView More